PSCM
MRK icon

Per Stirling Capital Management’s Merck MRK Stock Holding History

Per Stirling Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Buy
3,821
+52
+1% +$6.09K 0.05% 223
2026
Q1 		$453K Buy
3,769
+132
+4% +$15.2K 0.05% 209
2025
Q4 		$383K Buy
3,637
+2
+0.1% +$188 0.04% 216
2025
Q3 		$305K Buy
3,635
+63
+2% +$5.19K 0.04% 224
2025
Q2 		$283K Sell
3,572
-311
-8% -$24.7K 0.04% 226
2025
Q1 		$349K Buy
3,883
+420
+12% +$39.2K 0.05% 201
2024
Q4 		$345K Sell
3,463
-555
-14% -$57.2K 0.05% 204
2024
Q3 		$456K Buy
4,018
+504
+14% +$59.9K 0.06% 192
2024
Q2 		$435K Sell
3,514
-101
-3% -$13K 0.07% 172
2024
Q1 		$477K Sell
3,615
-76
-2% -$9.37K 0.08% 148
2023
Q4 		$402K Buy
3,691
+85
+2% +$8.82K 0.07% 150
2023
Q3 		$371K Sell
3,606
-89
-2% -$9.59K 0.08% 143
2023
Q2 		$426K Buy
3,695
+99
+3% +$11.2K 0.09% 137
2023
Q1 		$383K Sell
3,596
-220
-6% -$23.8K 0.08% 137
2022
Q4 		$423K Buy
+3,816
New +$390K 0.08% 136

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Per Stirling Capital Management's MRK Position: Q2 2026 in Review

Per Stirling Capital Management increased its Merck (MRK) stake by 1.4% in Q2 2026, buying an estimated $6.09K and bringing the position to 3,821 shares worth $491K. The position accounts for 0.05% of the portfolio, ranked #223.

Per Stirling Capital Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Per Stirling Capital Management held 3,821 shares of Merck worth $491K as of Q2 2026.
  • Per Stirling Capital Management bought 52 Merck shares in Q2 2026, an estimated $6.09K.
  • Merck made up 0.05% of Per Stirling Capital Management's portfolio in Q2 2026, its #223 holding.
  • Per Stirling Capital Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Per Stirling Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.